FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2102924311> ?p ?o ?g. }

• W2102924311 endingPage "573" @default.
• W2102924311 startingPage "565" @default.
• W2102924311 abstract "Summary The efficacy and safety of zanolimumab (HuMax‐CD4) in patients with relapsed or refractory peripheral T Cell lymphoma (PTCL) was evaluated. Twenty‐one adult patients with relapsed or refractory CD4 + PTCL of non‐cutaneous type (angioimmunoblastic T cell lymphoma (AITL) n = 9, PTCL‐not otherwise specified (NOS) n = 7, anaplastic large cell lymphoma (ALCL) n = 4 and enteropathy type T cell lymphoma n = 1) were treated in a single‐arm multi‐centre study, with weekly intravenous infusions of zanolimumab 980 mg for 12 weeks. Median age was 69 years (range 26–85). Seventeen of the patients had advanced stage disease (Ann Arbor stages III–IV). Objective tumour responses were obtained in 24% of the patients with two complete responses unconfirmed (CRu) and three partial responses (PR). One of the CRus lasted more than 252 d. Responses were obtained in different PTCL entities: AITL ( n = 3), ALCL ( n = 1) and PTCL‐NOS ( n = 1). In general, the trial drug was well tolerated with no major toxicity. Zanolimumab at a dose of 980 mg weekly demonstrated clinical activity and an acceptable safety profile in this poor‐prognosis patient population, suggesting that the potential benefit combining zanolimumab with standard chemotherapy in the treatment of PTCL should be investigated." @default.
• W2102924311 created "2016-06-24" @default.
• W2102924311 creator A5003078312 @default.
• W2102924311 creator A5011398209 @default.
• W2102924311 creator A5028743667 @default.
• W2102924311 creator A5040624896 @default.
• W2102924311 creator A5044552090 @default.
• W2102924311 creator A5046049357 @default.
• W2102924311 creator A5049924304 @default.
• W2102924311 creator A5051605599 @default.
• W2102924311 creator A5061020169 @default.
• W2102924311 creator A5072887923 @default.
• W2102924311 creator A5087036589 @default.
• W2102924311 date "2010-08-18" @default.
• W2102924311 modified "2023-10-18" @default.
• W2102924311 title "Phase II trial of zanolimumab (HuMax-CD4) in relapsed or refractory non-cutaneous peripheral T cell lymphoma" @default.
• W2102924311 cites W1542628397 @default.
• W2102924311 cites W1895474562 @default.
• W2102924311 cites W1912693401 @default.
• W2102924311 cites W1969582706 @default.
• W2102924311 cites W1990107872 @default.
• W2102924311 cites W2022966684 @default.
• W2102924311 cites W2029854218 @default.
• W2102924311 cites W2036369606 @default.
• W2102924311 cites W2046519590 @default.
• W2102924311 cites W2058015212 @default.
• W2102924311 cites W2060499380 @default.
• W2102924311 cites W2063259521 @default.
• W2102924311 cites W2070578050 @default.
• W2102924311 cites W2072624318 @default.
• W2102924311 cites W2087713415 @default.
• W2102924311 cites W2087994782 @default.
• W2102924311 cites W2096393559 @default.
• W2102924311 cites W2097339599 @default.
• W2102924311 cites W2099492038 @default.
• W2102924311 cites W2100163251 @default.
• W2102924311 cites W2104041885 @default.
• W2102924311 cites W2116272602 @default.
• W2102924311 cites W2116636452 @default.
• W2102924311 cites W2127159379 @default.
• W2102924311 cites W2132343700 @default.
• W2102924311 cites W2133267160 @default.
• W2102924311 cites W2135848827 @default.
• W2102924311 cites W2138498369 @default.
• W2102924311 cites W2153665789 @default.
• W2102924311 cites W2160305510 @default.
• W2102924311 cites W2161984323 @default.
• W2102924311 cites W2167571754 @default.
• W2102924311 cites W2255549241 @default.
• W2102924311 cites W2416844197 @default.
• W2102924311 cites W4241632943 @default.
• W2102924311 cites W50755486 @default.
• W2102924311 cites W70385801 @default.
• W2102924311 doi "https://doi.org/10.1111/j.1365-2141.2010.08298.x" @default.
• W2102924311 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20629661" @default.
• W2102924311 hasPublicationYear "2010" @default.
• W2102924311 type Work @default.
• W2102924311 sameAs 2102924311 @default.
• W2102924311 citedByCount "71" @default.
• W2102924311 countsByYear W21029243112012 @default.
• W2102924311 countsByYear W21029243112013 @default.
• W2102924311 countsByYear W21029243112014 @default.
• W2102924311 countsByYear W21029243112015 @default.
• W2102924311 countsByYear W21029243112016 @default.
• W2102924311 countsByYear W21029243112017 @default.
• W2102924311 countsByYear W21029243112018 @default.
• W2102924311 countsByYear W21029243112019 @default.
• W2102924311 countsByYear W21029243112020 @default.
• W2102924311 countsByYear W21029243112021 @default.
• W2102924311 countsByYear W21029243112022 @default.
• W2102924311 countsByYear W21029243112023 @default.
• W2102924311 crossrefType "journal-article" @default.
• W2102924311 hasAuthorship W2102924311A5003078312 @default.
• W2102924311 hasAuthorship W2102924311A5011398209 @default.
• W2102924311 hasAuthorship W2102924311A5028743667 @default.
• W2102924311 hasAuthorship W2102924311A5040624896 @default.
• W2102924311 hasAuthorship W2102924311A5044552090 @default.
• W2102924311 hasAuthorship W2102924311A5046049357 @default.
• W2102924311 hasAuthorship W2102924311A5049924304 @default.
• W2102924311 hasAuthorship W2102924311A5051605599 @default.
• W2102924311 hasAuthorship W2102924311A5061020169 @default.
• W2102924311 hasAuthorship W2102924311A5072887923 @default.
• W2102924311 hasAuthorship W2102924311A5087036589 @default.
• W2102924311 hasBestOaLocation W21029243111 @default.
• W2102924311 hasConcept C121332964 @default.
• W2102924311 hasConcept C126322002 @default.
• W2102924311 hasConcept C141071460 @default.
• W2102924311 hasConcept C142424586 @default.
• W2102924311 hasConcept C203014093 @default.
• W2102924311 hasConcept C2776090121 @default.
• W2102924311 hasConcept C2776365654 @default.
• W2102924311 hasConcept C2776694085 @default.
• W2102924311 hasConcept C2777872185 @default.
• W2102924311 hasConcept C2777891184 @default.
• W2102924311 hasConcept C2779338263 @default.
• W2102924311 hasConcept C2908647359 @default.
• W2102924311 hasConcept C31760486 @default.
• W2102924311 hasConcept C71924100 @default.

• next